Clinical Research
BibTex RIS Cite

Long-Term Effects of COVID-19 on Respiratory Symptoms and Asthma Control in Pediatric Patients with Asthma

Year 2024, Volume: 18 Issue: 2, 117 - 123, 18.03.2024
https://doi.org/10.12956/tchd.1354529

Abstract

Objective: After Covid-19 infection, many patients complain of persistent symptoms. There are limited studies evaluating the long-term consequences of COVID-19, in pediatric patients with asthma. The aim of this study is to evaluate the persistence of symptoms and asthma control in asthmatic children during follow-up after COVID-19 infection.
Material and Methods: Children with asthma who were admitted to our hospital between March 11, 2020, and August 31, 2021, for COVID-19 infection were included. Patients were evaluated for long- term symptoms and asthma control through phone interviews at least 6 months after infection.
Results: Eighty-five children with asthma were evaluated. The median duration of follow-up was 20 months. Patients experiencing symptoms after 1 month, 3 month and 6 month of COVID were 45.8% (n:39), 30.6% (n:26), and 23.5% (n:20) respectively. The most common symptom was cough. No significant relationship was found between time period from the date of COVID-19 to phone call and symptom persistence. Patients adopting a new pet and having stress were significantly higher in group of patients having symptoms at first month. Frequency of being well controlled was not different before and at 1 and 6 month of infection.
Conclusion: This study suggests that respiratory symptoms may persist in pediatric asthma patients for an extended period after COVID-19 infection.

References

  • Jiang F, Deng L, Zhang L, Cai Y, Cheung CW, Xia Z. Review of Clinical Characteristics of coronavirus disease 2019 (COVID-19). J Gen Intern Med 2020;35:1545-9.
  • Ludvigsson J. Systematic review of COVID-19 in children shows milder cases and a better prognosis than adults. Acta Paediatr 2020;109:1088-95.
  • CDC COVID data tracker [Internet]. Available from: https://covid.cdc.gov/covid- data- tracker/#demographics.2022.
  • Chibba KD, Patel GB, Vu THT. Prevalence and characterization of asthma in hospitalized and non-hospitalized patients with COVID-19. J Allergy Clin Immunol 2020;146:307-314.e4.
  • https://www.cdc.gov/asthma/most_recent_national_asthma_data.htm.2022.
  • Selçuk ZT, Demir AU, Tabakoglu E, Caglar T. Prevalence of asthma and allergic diseases in primary school children in Edirne, Turkey, two surveys 10 years apart. Pediatr Allergy Immunol 2010;21:e711-7.
  • Bayram I, Güneşer-Kendirli S, Yılmaz M, Ufuk Altıntaş D, Alparslan N, Bingöl Karakoç G. The prevelance of asthma and allergic diseases in children of school age in Adana in southern Turkey. In Turk J Pediatr 2004;46:221-5.
  • Metbulut AP, Mustafaoğlu Ö, Şen G, et al. Evaluation of Clinical and laboratory findings of asthmatic children with SARS-CoV-2 infection. Int Arch Allergy Immunol 2021;182:989-96.
  • https://www.cdc.gov/coronavirus/2019-ncov/need-extra-precautions/asthma.html.2022
  • https://blogs.cdc.gov/publichealthmatters/2020/04/asthma/.2022
  • https://ginasthma.org/gina-reports/2022.
  • Carfì A, Bernabei R, Landi F, Gemelli Against C-P-ACSG. Persistent symptoms in patients after Acute COVID-19. JAMA 2020;324:603–05.
  • Chopra V, Flanders SA, O’Malley M, Malani AN, Prescott HC. Sixty- day outcomes among patients hospitalized with COVID-19. Ann Intern Med 2020;11:M20–5661.
  • Afrin LB, Weinstock LB, Molderings GJ. Covid-19 hyperin amma- tion and post- Covid-19 illness may be rooted in mast cell activation syndrome. Int J Infect Dis 2020;100:327–32.
  • Dobkin SCL, Collaco JM, McGrath-Morrow S. Protracted respiratory findings in children post-SARS-Cov-2 infection. Pediatr Pulmonol 2021;56:3682-7.
  • Hoffman CL, Thibault M, Hong J. Characterizing pet acquisition and retention during the COVID-19 pandemic. Front Vet Sci 2021;8:781403.
  • Kalinowski J, Wurtz H, Baird M, Willen S. Shouldering the load yet again: Black women’s experiences of stress during COVID-19. SSM Ment Health 2022;12:100140.
  • Song WJ, Hui CKM, Hull JH, Birring SS, McGarvey L, Mazzone SB, Chung KF. Confronting COVID-19-associated cough and the post-COVID syndrome: role of viral neurotropism, neuroinflammation, and neuroimmune responses. Lancet Respir Med 2021;9:533-44.
  • López Castro J. Post-COVID-19 syndrome (PC19S): chronic reactive endotheliitis and disseminated vascular disease. Acta Med Port 2020;33:859.
  • Yang Z, Wang X, Wan XG, Wang ML, Qiu ZH, Chen JL, et al. Pediatric asthma control during the COVID-19 pandemic: A systematic review and meta-analysis. Pediatr Pulmonol 2022;57:20-5.
  • Moreno-Sanchez E, Castillo-Viera E, Velez-Moreno E, Gago-Valiente FJ. Facts and challenges about asthma and COVID-19 among paediatric population: A systematic literature review. Medicina (Kaunas) 2021;57:1306.

Coronavirüs enfeksiyonu olan pediatrik astımlı hastaların uzun vadede değerlendirilmesi

Year 2024, Volume: 18 Issue: 2, 117 - 123, 18.03.2024
https://doi.org/10.12956/tchd.1354529

Abstract

Amaç: Çalışmanın amacı, COVİD-19 enfeksiyonu sonrası astımlı çocukların persistan semptomlarını ve astım control durumlarını değerlendirmektir.
Gereç ve Yöntemler: Çalışmaya 11 Mart 2020 ve 31 Ağustos 2021 arasında astım tanısı olan ve COVİD-19 enfeksiyonu olan çocuklar alınmıştır. Hastalara telefon görüşmesi aracılığıyla, COVİD-19 enfeksiyonundan en az 6 ay sonra, uzun dönem semptom ve astım kontrolü için değerlendirildi.
Bulgular: Astımlı 58 çocuk değerlendirildi. Ortanca izlem süresi 20 aydı. COVİD-19 enfeksiyonundan 1, 3 ve 6 ay sonra halen semptomu olan hastalar sırasıyla %45.8 (n:39), %30.6 (n:26), ve %23.5 (n:20) olarak saptandı. En sık saptanan semptom öksürüktü. COVİD-19 enfeksiyonu geçirdikleri tarihten telefon görüşmesine kadar olan süre ile semptom persistansı arasında anlamlı ilişki saptanmadı. COVİD-19 enfeksiyonu sonrası 1.ayında semptomu sebat edenlerde anlamlı olarak yeni evcil hayvan sahiplenme ve stresli olma daha fazla saptandı.
Astımda iyi kontrollü olma durumu enfeksiyon öncesi dönem, enfeksiyon sonrası 1. ve 6.ayda anlamlı olarak farklı olmadığı saptandı.
Sonuç: Bu çalışma, pediatrik astım tanısı olan çocuklarda semptomların uzun süre devam edebileceğini göstermektedir.

References

  • Jiang F, Deng L, Zhang L, Cai Y, Cheung CW, Xia Z. Review of Clinical Characteristics of coronavirus disease 2019 (COVID-19). J Gen Intern Med 2020;35:1545-9.
  • Ludvigsson J. Systematic review of COVID-19 in children shows milder cases and a better prognosis than adults. Acta Paediatr 2020;109:1088-95.
  • CDC COVID data tracker [Internet]. Available from: https://covid.cdc.gov/covid- data- tracker/#demographics.2022.
  • Chibba KD, Patel GB, Vu THT. Prevalence and characterization of asthma in hospitalized and non-hospitalized patients with COVID-19. J Allergy Clin Immunol 2020;146:307-314.e4.
  • https://www.cdc.gov/asthma/most_recent_national_asthma_data.htm.2022.
  • Selçuk ZT, Demir AU, Tabakoglu E, Caglar T. Prevalence of asthma and allergic diseases in primary school children in Edirne, Turkey, two surveys 10 years apart. Pediatr Allergy Immunol 2010;21:e711-7.
  • Bayram I, Güneşer-Kendirli S, Yılmaz M, Ufuk Altıntaş D, Alparslan N, Bingöl Karakoç G. The prevelance of asthma and allergic diseases in children of school age in Adana in southern Turkey. In Turk J Pediatr 2004;46:221-5.
  • Metbulut AP, Mustafaoğlu Ö, Şen G, et al. Evaluation of Clinical and laboratory findings of asthmatic children with SARS-CoV-2 infection. Int Arch Allergy Immunol 2021;182:989-96.
  • https://www.cdc.gov/coronavirus/2019-ncov/need-extra-precautions/asthma.html.2022
  • https://blogs.cdc.gov/publichealthmatters/2020/04/asthma/.2022
  • https://ginasthma.org/gina-reports/2022.
  • Carfì A, Bernabei R, Landi F, Gemelli Against C-P-ACSG. Persistent symptoms in patients after Acute COVID-19. JAMA 2020;324:603–05.
  • Chopra V, Flanders SA, O’Malley M, Malani AN, Prescott HC. Sixty- day outcomes among patients hospitalized with COVID-19. Ann Intern Med 2020;11:M20–5661.
  • Afrin LB, Weinstock LB, Molderings GJ. Covid-19 hyperin amma- tion and post- Covid-19 illness may be rooted in mast cell activation syndrome. Int J Infect Dis 2020;100:327–32.
  • Dobkin SCL, Collaco JM, McGrath-Morrow S. Protracted respiratory findings in children post-SARS-Cov-2 infection. Pediatr Pulmonol 2021;56:3682-7.
  • Hoffman CL, Thibault M, Hong J. Characterizing pet acquisition and retention during the COVID-19 pandemic. Front Vet Sci 2021;8:781403.
  • Kalinowski J, Wurtz H, Baird M, Willen S. Shouldering the load yet again: Black women’s experiences of stress during COVID-19. SSM Ment Health 2022;12:100140.
  • Song WJ, Hui CKM, Hull JH, Birring SS, McGarvey L, Mazzone SB, Chung KF. Confronting COVID-19-associated cough and the post-COVID syndrome: role of viral neurotropism, neuroinflammation, and neuroimmune responses. Lancet Respir Med 2021;9:533-44.
  • López Castro J. Post-COVID-19 syndrome (PC19S): chronic reactive endotheliitis and disseminated vascular disease. Acta Med Port 2020;33:859.
  • Yang Z, Wang X, Wan XG, Wang ML, Qiu ZH, Chen JL, et al. Pediatric asthma control during the COVID-19 pandemic: A systematic review and meta-analysis. Pediatr Pulmonol 2022;57:20-5.
  • Moreno-Sanchez E, Castillo-Viera E, Velez-Moreno E, Gago-Valiente FJ. Facts and challenges about asthma and COVID-19 among paediatric population: A systematic literature review. Medicina (Kaunas) 2021;57:1306.
There are 21 citations in total.

Details

Primary Language English
Subjects Clinical Sciences (Other)
Journal Section ORIGINAL ARTICLES
Authors

Azize Pınar Metbulut 0000-0001-8823-5960

Deniz Yılmaz 0000-0002-9961-8016

İlknur Külhaş Çelik 0000-0003-3812-9654

Ersoy Civelek 0000-0003-0814-5637

Emine Dibek Mısırlıoğlu 0000-0002-3241-2005

Muge Toyran 0000-0002-2490-0551

Early Pub Date January 15, 2024
Publication Date March 18, 2024
Submission Date September 16, 2023
Published in Issue Year 2024 Volume: 18 Issue: 2

Cite

Vancouver Metbulut AP, Yılmaz D, Külhaş Çelik İ, Civelek E, Dibek Mısırlıoğlu E, Toyran M. Long-Term Effects of COVID-19 on Respiratory Symptoms and Asthma Control in Pediatric Patients with Asthma. Türkiye Çocuk Hast Derg. 2024;18(2):117-23.


The publication language of Turkish Journal of Pediatric Disease is English.


Manuscripts submitted to the Turkish Journal of Pediatric Disease will go through a double-blind peer-review process. Each submission will be reviewed by at least two external, independent peer reviewers who are experts in the field, in order to ensure an unbiased evaluation process. The editorial board will invite an external and independent editor to manage the evaluation processes of manuscripts submitted by editors or by the editorial board members of the journal. The Editor in Chief is the final authority in the decision-making process for all submissions. Articles accepted for publication in the Turkish Journal of Pediatrics are put in the order of publication, with at least 10 original articles in each issue, taking into account the acceptance dates. If the articles sent to the reviewers for evaluation are assessed as a senior for publication by the reviewers, the section editor and the editor considering all aspects (originality, high scientific quality and citation potential), it receives publication priority in addition to the articles assigned for the next issue.


The aim of the Turkish Journal of Pediatrics is to publish high-quality original research articles that will contribute to the international literature in the field of general pediatric health and diseases and its sub-branches. It also publishes editorial opinions, letters to the editor, reviews, case reports, book reviews, comments on previously published articles, meeting and conference proceedings, announcements, and biography. In addition to the field of child health and diseases, the journal also includes articles prepared in fields such as surgery, dentistry, public health, nutrition and dietetics, social services, human genetics, basic sciences, psychology, psychiatry, educational sciences, sociology and nursing, provided that they are related to this field. can be published.